Trending
September 17, 2024 REGENXBIO Appoints Mitchell Chan as Chief Financial OfficerSeptember 11, 2024 Frank Bonsal-backed CSA Medical Raises $53M to Advance Regenerative Bronchitis TherapySeptember 4, 2024 T. Rowe Price Joins $325 Million Financing for ArsenalBioAugust 28, 2024 NRx Pharma Subsidiary HOPE Therapeutics Secures $30M to Buy Ketamine ClinicsAugust 27, 2024 PreciseDx Uses AI to Predict Recurrence of Breast Cancer
Featured
September 17, 2024
REGENXBIO Appoints Mitchell Chan as Chief Financial Officer
REGENXBIO Inc. (Nasdaq: RGNX) today announced that Mitchell Chan has been appointed as Executive Vice President and... Read more »
September 11, 2024
Frank Bonsal-backed CSA Medical Raises $53M to Advance Regenerative Bronchitis Therapy
Frank Bonsal Jr.-backed CSA Medical, which has developed a new therapy to treat chronic bronchitis, has closed a $53... Read more »
September 4, 2024
T. Rowe Price Joins $325 Million Financing for ArsenalBio
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Arsenal Biosciences, Inc., a clinical stage programmable cell therapy... Read more »
September 10, 2024
Lorien Health Services Leads the Way in Addressing Nursing Shortage with Annual ‘Signing Day’ Event
September 5, 2024
Verato Recognized in 2024 Gartner Hype Cycle Report for Real-Time Health System Technologies
